Efficacy of 1-day prophylaxis medication with fluoroquinolone for prostate biopsy
- First Online:
- 127 Downloads
A prospective, randomized trial in which 236 patients received oral levofloxacin, either at 600 mg/day for 1 day (n=124) or 300 mg/day for 3 days (n=112). Urinalysis, plasma white blood cell count (WBC) (per mm3), and C reactive protein (CRP) (mg/dl) levels were checked before prostate biopsy (PBX), on the day after PBX, and on the seventh day after PBX. Two patients (1.61%) who received 600 mg for 1 day and 2 patients (1.79%) who received 300 mg for 3 days had febrile infectious complications. There was no statistically significant difference between levofloxacin at 600 mg for 1 day and levofloxacin at 300 mg for 3 days regarding the elevation of WBC and CRP. We can perform PBX safely with levofloxacin at 600 mg for 1 day as prophylaxis and recommend this method from the point of view of the decrease of antibiotic-resistant strains.
KeywordsProstate biopsy Prophylaxis Infectious complication Levofloxacin 1 day
- 11.Fournier G, Valeri A, Mangin P, Cussenot O (2004) Prostate cancer: diagnosis and staging. Ann Urol (Paris) 38:207–224Google Scholar
- 14.Isen K, Kupeli B, Sinik Z, Sozen S, Bozkirli I (1999) Antibiotic prophylaxis for transrectal biopsy of the prostate: a prospective randomized study of the prophylactic use of single dose oral fluoroquinolone versus trimethoprim-sulfamethoxazole. Int Urol Nephrol 31:491–495CrossRefPubMedGoogle Scholar
- 16.Larsen EH, Gasser TC, Madsen PO (1986) Antimicrobial prophylaxis in urologic surgery. Urol Clin North Am 4:591–604Google Scholar